# ADVA ACE Coronary Stent System in Coronary Artery Disease Patients (ADVANCE)

Study · id `cardio:ct-nct07912541` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07912541](<https://clinicaltrials.gov/study/NCT07912541>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT07912541

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 110 participants.

## Technical summary

Registry record NCT07912541. Allocation not applicable; no masking; primary purpose treatment. Start 2026-11 (anticipated); primary completion 2028-11 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 110 participants (planned count; ClinicalTrials.gov record NCT07912541, source copy `cardio:ctgov-nct07912541-2026-11-03`, retrieved 2026-11-18)
- Planned start: 2026-11 (anticipated) (ClinicalTrials.gov record NCT07912541, source copy `cardio:ctgov-nct07912541-2026-11-03`, retrieved 2026-11-18)
- Primary completion: 2028-11 (anticipated) (ClinicalTrials.gov record NCT07912541, source copy `cardio:ctgov-nct07912541-2026-11-03`, retrieved 2026-11-18)
- Completion: 2029-05 (anticipated) (ClinicalTrials.gov record NCT07912541, source copy `cardio:ctgov-nct07912541-2026-11-03`, retrieved 2026-11-18)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07912541-2026-11-03`, retrieved 2026-11-18)

## The registry's words

- Brief title: ADVA ACE Coronary Stent System in Coronary Artery Disease Patients (ADVANCE)
- Acronym: ADVANCE
- Condition: Coronary Artery Disease
- Condition: De Novo Stenosis Lesion
- Condition: Coronary Stent Implantation
- Intervention (Device): ADVA ACE Everolimus Eluting Coronary Stent System
- Lead sponsor: Advanced MedTech Solutions Pvt. Ltd.
- Lead sponsor class: OTHER
- Collaborator: Clicebo Solutions Private Limited
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)

## Provenance

Content hash: 68a24597df15f7b323b50dbcd4884e9b6b69080f2761a72ca5db00bb299f1c99
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
